)
Visual
test
CellaVision
CellaVision (CEVI) investor relations material
CellaVision Q4 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q4 2025 earnings summary5 Feb, 2026
Executive summary
Q4 2025 saw strong organic sales growth of 12.2% year-over-year, with net sales rising 5.6% to SEK 197 million, driven by robust demand in the Americas and EMEA, while APAC declined due to tough comparables.
Full-year 2025 net sales reached SEK 759 million, up 5% from 2024, with organic growth of 9% and significant milestones including CE Mark for a new bone marrow application and a major software upgrade.
EBITDA margin remained stable at 33%, and profit before tax increased to SEK 55 million from SEK 51 million in Q4 2024.
The Board proposes increasing the dividend to SEK 2.75 per share, up from SEK 2.5.
Financial highlights
Q4 net sales rose 5.6% to SEK 197 million, with organic growth of 12.2% after a -6.6% FX headwind.
EBITDA for Q4 was SEK 65 million (33% margin), exceeding the 30% target.
Gross margin for Q4 was 67%, slightly lower due to software mix and FX effects.
Full-year revenue reached SEK 759 million, with a gross margin of 68% and total cash flow of SEK 40 million.
Cash position at year-end was SEK 188 million, with low debt and an equity ratio of 81%.
Outlook and guidance
Strong momentum in the Americas is expected to continue into H1 2026, with no signs of slowdown.
Bone marrow application sales in Europe are anticipated in H2 2026, especially Q4.
Methanol-free reagent launch in the U.S. is planned for 2026, with incremental revenue expected late in the year.
Continued high R&D costs are expected in 2026, in line with earlier quarters.
Continued focus on innovation and strategic priorities, with new product launches in hematology planned for 2026 and beyond.
BMA Application market potential
APAC sales recovery outlook for 2026
Gross margin trend and sales mix impact
Outlook for R&D spend and capitalization in 2026
FPM technology's potential beyond hematology
DC-1 momentum in US integrated health networks
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Latest summaries
- TimeTickerHeadlineOpen
- 6 FebCRI
Q1 2025 saw record revenue, a return to profit, and major new contracts in space technology. - 6 FebCRINet loss widened to 7.5m PLN in H1 2024 as revenue fell and R&D costs remained high.
- 6 FebCRINet loss deepened on lower sales and higher costs, but major new contracts and restructuring are underway.
- 6 FebEMBASSY
Record revenue, NOI, and distributions highlight strong growth and robust segment performance. - 6 FebCRIRevenue fell and losses deepened, but ESA contracts and R&D projects drive future prospects.
- 6 FebNVDA
AI-driven digital twins and real-time simulation will transform engineering and manufacturing. - 6 FebTUPRS
Net income reached TRY 29.5 billion, with strong dividends and a robust net cash position. - 6 FebCPT
2025 results beat guidance; Sun Belt focus, asset sales, and share buybacks drive 2026 strategy. - 6 FebCRIH1 2025 saw a return to profit, record revenues, and strong cash from major space projects.
- 6 FebSCW
Q2 2025 revenue up 120% y/y, driven by record Asian contract and backlog growth.
Next CellaVision earnings date
Q1 202624 Apr, 2026
CellaVision
Next CellaVision earnings date
Q1 202624 Apr, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
CellaVision AB offers systems for automated and digital analysis of body fluids in health care services sector. It provides digital solutions for blood and body fluids analysis; image-based systems for microscopic analysis and clinical review of body fluids, such as peripheral blood film, and urine analysis; lab automation solutions; and software solutions, including Cellavision DM96, a complete solution that consists of an analyzer, instrument camera, computer, software environment with proprietary algorithms, ready-to-use reagents, and quality control material. The company also has integration solutions to hospital information systems and other laboratory systems. CellaVision AB was incorporated in 1994 and is headquartered in Lund, Sweden.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage